TypeZero Technologies
Digital health and personalized medicine company revolutionizing the treatment and management of diabetes.
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor | €0.0 | round |
| investor | €0.0 | round | |
| N/A | €0.0 | round | |
| N/A | €0.0 | round | |
N/A | Acquisition | ||
| Total Funding | 000k | ||
Related Content
TypeZero Technologies specializes in providing advanced API solutions that enable developers to integrate Dexcom Continuous Glucose Monitoring (CGM) data into their diabetes management applications. The company operates in the healthcare technology sector, focusing on enhancing the utility and value of CGM data for both patients and healthcare providers. TypeZero's primary clients include app developers, healthcare providers, and technology companies looking to innovate in the diabetes care space. The business model revolves around offering API access and support services, generating revenue through subscription fees and licensing agreements. By facilitating the integration of real-time glucose data, events, and statistics, TypeZero aims to empower individuals to take control of their diabetes management, ultimately improving health outcomes.
Keywords: API, CGM data, diabetes management, healthcare technology, app integration, real-time data, glucose monitoring, subscription model, licensing, health outcomes.